US Patent 7972813 Tetrodotoxin-resistant sodium channel alpha subunit
Patent 7972813 was granted and assigned to Vertex Pharmaceuticals on July, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+148 characters)
Article
Patent abstract
The present invention is directed to a chimp sodium channel alpha subunit and methods and compositions for making and using the same.
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Christopher Raj Dinesh0
Kenneth McCormack0
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07972813 Tetrodotoxin-resistant sodium channel alpha subunit US Patent 7972813 Tetrodotoxin-resistant sodium channel alpha subunit
Infobox
Patent Number
079728130
Patent Number
79728130
Edits on 21 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079728130
Date of Patent
July 5, 2011
0Patent Application Number
115401430
Date Filed
September 29, 2006
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07972813 Tetrodotoxin-resistant sodium channel alpha subunit
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07972813
Date of patent
July 5, 2011
Patent application number
11540143
Date Filed
September 29, 2006
Patent primary examiner
Find more entities like US Patent 7972813 Tetrodotoxin-resistant sodium channel alpha subunit
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
